NephrologyShanghai Qilu Pharmaceutical Research patents new sGC activatorsShanghai Qilu Pharmaceutical Research Development Centre Ltd. has identified soluble guanylate cyclase (sGC) activators that are potentially useful for the treatment of chronic kidney disease and diabetic nephropathy.